AIBD

A straightforward discussion drove toward attendees toward the more current understanding of the clinical and genetic overlap between the 2 major forms of IBD.

Extraintestinal manifestations of inflammatory bowel disease affect the musculoskeletal, dermatologic, ocular, renal and pulmonary systems.

Therapy for ulcerative colitis and Crohn disease has been transformed with the introduction of anti–tumor necrosis factor treatment, according to University of Miami authors.

A diet high in fats and protein increases the risk of developing ulcerative colitis and Crohn’s disease, researchers found. Hou and colleagues performed a systematic review to evaluate the association between diet and risk of inflammatory bowel disease (IBD)

Despite a lower prevalence of traditional risk factors-such as hypertension and diabetes-patients with inflammatory bowel disease (IBD) have a higher incidence of stroke, said researchers at the University of Miami.

Does upper endoscopy affect the diagnosis or management of adults with colitis? No, say investigators from Cedars-Sinai Medical Center in Los Angeles, although the procedure is routinely performed in children with inflammatory bowel disease (IBD) of the colon.

Quality of life in children and adolescents with inflammatory bowel disease (IBD) is a key focus of research presented at the 2010 Advances in IBD conference in Hollywood, Florida. Two of the top abstracts address social isolation and patient adherence to medication regimens among teenagers with IBD.

Ulcerative colitis affects about 500,000 persons in the United States and accounts for more than 30,000 hospitalizations and 1 million workdays lost each year. The exacerbations and remissions that characterize the clinical course of the disease can make its management particularly challenging. What is the optimal approach to treatment? And which agents are most effective for maintenance therapy?

More than 1000 clinicians and researchers from all over the world will gather in Hollywood, Florida, this week for the 2010 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Conference. The featured speaker is Jean-Frederic Colombel, MD, Professor of Hepatogastroenterology at Centre Hospitalier Universitaire de Lille, France, who will discuss management strategies to improve the quality of care of patients with IBD.